S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

RDHL Redhill Biopharma Ltd

0.469

0.0377 (8.74%)

After Hours

Last Updated: 18:27:55

Delayed by 15 minutes

RedHill increases bought deal offering to $35M

To read the full story on Seeking Alpha, click here.

Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Redhill Biopharma Charts.

Redhill Biopharma (NASDAQ:RDHL)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Redhill Biopharma Charts.

Redhill Boipharma Ltd News

RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
Wednesday 24 April 2024 (1 week ago) • PR Newswire (US)

RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Monday 8 April 2024 (3 weeks ago) • PR Newswire (US)

RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
Tuesday 2 April 2024 (4 weeks ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

RedHill Announces New USPTO Patent Covering Talicia® Through 2034
Monday 11 March 2024 (2 months ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
Tuesday 5 March 2024 (2 months ago) • PR Newswire (US)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)

RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication
Tuesday 20 February 2024 (2 months ago) • PR Newswire (US)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Friday 16 February 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Thursday 15 February 2024 (2 months ago) • Edgar (US Regulatory)

More Redhill Boipharma Ltd News Articles

Global Developments (PK)

NaturalShrimp (QB)

Mullen Automotive

FBEC Worldwide (PK)

Umbra Applied Technologies (PK)

Wanderport (PK)

NioCorp Developments

Branded Legacy (PK)

Fannie Mae (QB)

International Star (PK)

Tonner One World (PK)

Virexit Technologies (PK)

TideRock Companies (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions